Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionLegal & General Group Plc
Latest Disclosed Ownership219,680 shares
Latest Disclosed Value $ 8,855,286
Legal & General Group Plc reports 10.34% decrease in ownership of HTD / Corcept Therapeutics Incorporated

On May 8, 2026 - Legal & General Group Plc filed a 13F-HR form disclosing ownership of 219,680 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $7,576,763 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 245,009 shares of Corcept Therapeutics Incorporated. This represents a change in shares of -10.34% during the quarter. The current value of the position is $13,892,563 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 219,680 -25,329 -10.34 8,855 3.86 0.0020
2026-02-09 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 245,009 -41,791 -14.57 8,526 -64.23 0.0019
2025-11-13 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 286,800 -12,022 -4.02 23,836 8.67 0.0053
2025-08-12 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 298,822 28,685 10.62 21,934 -28.92 0.0054
2025-05-15 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 270,137 -8,012 -2.88 30,855 120.16 0.0084
2025-02-13 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 278,149 9,143 3.40 14,016 12.58 0.0037
2025-02-28 2024-09-30 13F/A-2 CORCEPT THERAPEUTICS COM 218352102 269,006 6,229 2.37 12,450 45.82 0.0033
2024-11-14 2024-09-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 278,146 6,229 12,873 0.0027
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 278,146 6,229 12,873 0.0014
2025-05-29 2024-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 262,777 10,334 4.09 8,538 34.25 0.0024
2024-08-14 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 271,917 19,474 8,835 0.0020
2025-05-29 2024-03-31 13F/A-2 CORCEPT THERAPEUTICS COM 218352102 252,443 980 0.39 6,359 -22.14 0.0018
2024-07-01 2024-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 252,443 980 6,359 0.0015
2024-05-14 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 248,278 -3,185 6,254 0.0008
2025-05-29 2023-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 251,463 3,276 1.32 8,168 20.80 0.0025
2024-02-15 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 251,463 3,276 8,168 0.0021
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 248,187 -8,706 -3.39 6,762 18.30 0.0024
2023-08-14 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 256,893 -22,468 -8.04 5,716 -5.54 0.0019
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 279,361 -852 -0.30 6,051 6.31 0.0022
2023-02-14 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 280,213 5,799 2.11 5,691 -19.10 0.0022
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 274,414 -1,388 -0.50 7,035 7.26 0.0027
2022-08-22 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 275,802 -2,341 -0.84 6,559 4.71 0.0023
2022-05-16 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 278,143 -869 -0.31 6,264 13.38 0.0019
2022-02-14 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 279,012 -11,199 -3.86 5,525 -3.26 0.0017
2021-11-15 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 290,211 21,107 7.84 5,711 -3.55 0.0019
2021-08-12 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 269,104 -72,015 -21.11 5,921 -27.05 0.0020
2021-05-17 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 341,119 10,136 3.06 8,116 -6.26 0.0030
2021-02-12 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 330,983 6,856 2.12 8,658 53.48 0.0034
2020-11-13 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 324,127 5,894 1.85 5,641 5.38 0.0025
2020-08-14 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 318,233 21,796 7.35 5,353 51.86 0.0026
2020-05-14 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 296,437 954 0.32 3,525 -1.40 0.0021
2020-02-13 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 295,483 31,810 12.06 3,575 21.60 0.0017
2019-08-14 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 263,673 198 0.08 2,940 -4.95 0.0016
2019-05-15 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 263,475 22,431 9.31 3,093 -3.16 0.0018
2019-02-15 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 241,044 -2,351 -0.97 3,194 -5.78 0.0025
2018-11-20 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 243,395 35,007 16.80 3,390 3.32 0.0024
2018-08-10 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 208,388 13,036 6.67 3,281 3.27 0.0025
2018-05-17 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 195,352 22,531 13.04 3,177 1.79 0.0024
2018-02-13 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 172,821 148,931 623.40 3,121 581.44 0.0023
2017-11-09 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 23,890 629 2.70 458 65.94 0.0003
2017-08-03 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 23,261 5,623 31.88 276 40.82 0.0002
2017-05-12 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 17,638 -276 -1.54 196 49.62 0.0002
2017-02-13 2016-12-31 13F CORCEPT THERAPEUTICS COM 218352102 17,914 8,012 80.91 131 107.94 0.0001
2016-10-12 2016-09-30 13F CORCEPT THERAPEUTICS COM 218352102 9,902 0 0.00 63 16.67 0.0001
2016-08-16 2016-06-30 13F CORCEPT THERAPEUTICS COM 218352102 9,902 9,902 54 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.